Group One Trading’s Ventyx Biosciences VTYX Stock Holding History

Group One Trading’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-156,600	Closed	-$1.41M	–	8866
2025 Q4	$1.41M	Buy	156,600 +153,600	+5,120%	+$1.15M	﹤0.01%	2585
2025 Q3	$9.33K	Sell	3,000 -92,700	-97%	-$246K	﹤0.01%	7210
2025 Q2	$205K	Buy	95,700 +90,000	+1,579%	+$145K	﹤0.01%	4321
2025 Q1	$6.55K	Buy	5,700 +4,100	+256%	+$7.04K	﹤0.01%	6516
2024 Q4	$3.5K	Sell	1,600 -74,900	-98%	-$170K	﹤0.01%	6566
2024 Q3	$167K	Buy	76,500 +9,500	+14%	+$21.8K	﹤0.01%	3785
2024 Q2	$155K	Buy	67,000 +26,500	+65%	+$110K	﹤0.01%	3613
2024 Q1	$223K	Buy	40,500 +21,100	+109%	+$96.5K	﹤0.01%	3478
2023 Q4	$47.9K	Buy	19,400 +4,200	+28%	+$39.9K	﹤0.01%	5089
2023 Q3	$528K	Buy	15,200 +5,500	+57%	+$190K	﹤0.01%	2851
2023 Q2	$318K	Sell	9,700 -9,800	-50%	-$338K	﹤0.01%	3489
2023 Q1	$653K	Buy	+19,500	New	+$758K	﹤0.01%	2506

Other funds holding VTYX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Group One Trading's VTYX Position: Q4 2025 in Review

Group One Trading sold out of Ventyx Biosciences (VTYX) in Q4 2025, closing a stake of 55,569 shares — an estimated $415K sold.

Group One Trading first reported a position in VTYX in Q4 2023 and held it in 8 quarters. The position peaked at $798K in Q4 2023. 139 funds tracked by Wall St. Rank hold VTYX as of Q4 2025.

Group One Trading reported no remaining Ventyx Biosciences position as of Q4 2025 after selling out during the quarter.
Group One Trading sold 55,569 Ventyx Biosciences shares in Q4 2025, an estimated $415K.
Group One Trading first reported a position in Ventyx Biosciences in Q4 2023 and held it in 8 quarters.
Group One Trading's Ventyx Biosciences position peaked at $798K in Q4 2023.
139 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.